Clinical trial · Interventional
Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth)
Evaluation of an Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Principal Investigator left Duke University
Summary
Brief summary (as posted)
The purpose of this single institution pilot study is to determine the feasibility of implementing an eHealth prostate cancer surveillance program through the eVisit electronic medical record patient portal. The investigators will assess patient compliance and satisfaction with eVisit follow up care in lieu of in person clinic visits.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| eVisit | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- eVisit
- description
- The study intervention will be an electronically performed surveillance program replacing face-to-face clinic follow-up visits. At 3 month intervals for 1 year, the patient will receive an email reminder generated by the patient portal to complete lab testing and eVisit questionnaire.
- interventionNames
- Other: eVisit
Primary outcomes (1)
- measure
- Proportion of patients who complete all scheduled eVisits at the end of follow-up
- timeFrame
- 12 months
- description
- Defined as completion of labwork and at least 80% of the questions asked at each eVisit
Secondary outcomes (8)
- measure
- Feasibility of enrollment to the eVisit program
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * ≥ 18 years old with histologically confirmed prostate cancer * Completed curative intent treatment to the prostate +/- pelvis * Deemed to be "without evidence of active disease" by treating provider with at least 1 follow up visit 3 or more months after treatment completion * MyChart account or willingness to open account * Access to the internet Exclusion Criteria: * Documented extrapelvic metastases * PSA meeting definition of recurrence (\>0.2 ng/ml for prostatectomy patients or nadir + 2 ng/ml for radiation patients) and rising with doubling time less than 1 year
References
Publications (0)
Data not yet available